Skip to main content
. 2020 Jun 19;35(3):701–711. doi: 10.1038/s41375-020-0892-z

Fig. 3. Clinical course of an AML patient reaching CRi in the TCP/ATRA trial.

Fig. 3

a Clinical course of the patient (03). b Numbers of leukocytes and thrombocytes in the peripheral blood and percentage of blasts in the bone marrow during treatment with TCP + ATRA. c Cell morphology of AML cells in the bone marrow at screening (left), at the end of the first cycle (middle), and at time of relapse (right). Bone marrow smears are stained with Pappenheim and shown at a magnification of 63×. Combination of TCP and ATRA led to morphologically complete remission after one cycle of TCP + ATRA. After the end of cycle three, patient developed relapse.